Long-term oncologic outcomes of robot-assisted versus open radical prostatectomy for prostate cancer with seminal vesicle invasion: a multi-institutional study with a minimum 5-year follow-up

[1]  H. Ten Have,et al.  Benefits and Harms , 2021, Dictionary of Global Bioethics.

[2]  S. Faraj,et al.  Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. , 2020, European urology.

[3]  C. Parker,et al.  Prostate Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  H. G. van der Poel,et al.  Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. , 2020, European urology.

[5]  A. D'Amico,et al.  Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[6]  Matthew P. Goetz,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[7]  V. Gebski,et al.  Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer , 2018, The New England journal of medicine.

[8]  Jason D. Wright,et al.  Survival after Minimally Invasive Radical Hysterectomy for Early‐Stage Cervical Cancer , 2018, The New England journal of medicine.

[9]  Vidit Sharma,et al.  Much ado about robotic versus open radical prostatectomy. , 2018, The Lancet. Oncology.

[10]  H. Samaratunga,et al.  Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. , 2018, The Lancet. Oncology.

[11]  H. G. van der Poel,et al.  The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. , 2017, European urology.

[12]  M. Cooperberg,et al.  Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer. , 2017, European urology.

[13]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[14]  M. Baghdadi,et al.  Surgical method influences specimen margins and biochemical recurrence during radical prostatectomy for high-risk prostate cancer: a systematic review and meta-analysis , 2017, World Journal of Urology.

[15]  Steven L. Chang,et al.  Robot-assisted Versus Open Radical Prostatectomy: A Contemporary Analysis of an All-payer Discharge Database. , 2016, European urology.

[16]  J Alfred Witjes,et al.  Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. , 2016, European urology.

[17]  L. Egevad,et al.  A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. , 2016, European urology.

[18]  K. Miller,et al.  Matched comparison of outcomes following open and minimally invasive radical prostatectomy for high-risk patients , 2014, World Journal of Urology.

[19]  Jeong Kon Kim,et al.  Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies. , 2013, The Journal of urology.

[20]  Kirsten L. Greene,et al.  How does robot‐assisted radical prostatectomy (RARP) compare with open surgery in men with high‐risk prostate cancer? , 2013, BJU international.

[21]  B. Trock,et al.  An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011 , 2013, BJU international.

[22]  Qiang Wu,et al.  Effects of robotic-assisted laparoscopic prostatectomy on surgical pathology specimens , 2012, Diagnostic Pathology.

[23]  R. Thompson,et al.  Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. , 2011, European urology.

[24]  A. Partin,et al.  A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy. , 2011, The Journal of urology.

[25]  S. Herrell,et al.  A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. , 2007, The Journal of urology.

[26]  Anthony V D'Amico,et al.  Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. , 2007, The Journal of urology.

[27]  P. Scardino,et al.  Cancer‐specific survival and predictors of prostate‐specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy , 2006, Cancer.

[28]  L. Egevad,et al.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.